Literature DB >> 22246389

Metabolism of [6]-shogaol in mice and in cancer cells.

Huadong Chen1, Lishuang Lv, Dominique Soroka, Renaud F Warin, Tiffany A Parks, Yuhui Hu, Yingdong Zhu, Xiaoxin Chen, Shengmin Sang.   

Abstract

Ginger has received extensive attention because of its antioxidant, anti-inflammatory, and antitumor activities. However, the metabolic fate of its major components is still unclear. In the present study, the metabolism of [6]-shogaol, one of the major active components in ginger, was examined for the first time in mice and in cancer cells. Thirteen metabolites were detected and identified, seven of which were purified from fecal samples collected from [6]-shogaol-treated mice. Their structures were elucidated as 1-(4'-hydroxy-3'-methoxyphenyl)-4-decen-3-ol (M6), 5-methoxy-1-(4'-hydroxy-3'-methoxyphenyl)-decan-3-one (M7), 3',4'-dihydroxyphenyl-decan-3-one (M8), 1-(4'-hydroxy-3'-methoxyphenyl)-decan-3-ol (M9), 5-methylthio-1-(4'-hydroxy-3'-methoxyphenyl)-decan-3-one (M10), 1-(4'-hydroxy-3'-methoxyphenyl)-decan-3-one (M11), and 5-methylthio-1-(4'-hydroxy-3'-methoxyphenyl)-decan-3-ol (M12) on the basis of detailed analysis of their (1)H, (13)C, and two-dimensional NMR data. The rest of the metabolites were identified as 5-cysteinyl-M6 (M1), 5-cysteinyl-[6]-shogaol (M2), 5-cysteinylglycinyl-M6 (M3), 5-N-acetylcysteinyl-M6 (M4), 5-N-acetylcysteinyl-[6]-shogaol (M5), and 5-glutathiol-[6]-shogaol (M13) by analysis of the MS(n) (n = 1-3) spectra and comparison to authentic standards. Among the metabolites, M1 through M5, M10, M12, and M13 were identified as the thiol conjugates of [6]-shogaol and its metabolite M6. M9 and M11 were identified as the major metabolites in four different cancer cell lines (HCT-116, HT-29, H-1299, and CL-13), and M13 was detected as a major metabolite in HCT-116 human colon cancer cells. We further showed that M9 and M11 are bioactive compounds that can inhibit cancer cell growth and induce apoptosis in human cancer cells. Our results suggest that 1) [6]-shogaol is extensively metabolized in these two models, 2) its metabolites are bioactive compounds, and 3) the mercapturic acid pathway is one of the major biotransformation pathways of [6]-shogaol.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246389      PMCID: PMC3310425          DOI: 10.1124/dmd.111.043331

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  44 in total

1.  Increased growth inhibitory effects on human cancer cells and anti-inflammatory potency of shogaols from Zingiber officinale relative to gingerols.

Authors:  Shengmin Sang; Jungil Hong; Hou Wu; Jing Liu; Chung S Yang; Min-Hsiung Pan; Vladimir Badmaev; Chi-Tang Ho
Journal:  J Agric Food Chem       Date:  2009-11-25       Impact factor: 5.279

2.  Profiling of the compounds absorbed in human plasma and urine after oral administration of a traditional Japanese (kampo) medicine, daikenchuto.

Authors:  Jun Iwabu; Junko Watanabe; Kazuhiro Hirakura; Yoshinori Ozaki; Kazuhiro Hanazaki
Journal:  Drug Metab Dispos       Date:  2010-08-05       Impact factor: 3.922

Review 3.  Glutathione and glutathione-related enzymes in reproduction. A review.

Authors:  M F Knapen; P L Zusterzeel; W H Peters; E A Steegers
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-02       Impact factor: 2.435

4.  Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analog chrysin in the Atlantic killifish.

Authors:  Petra A Tsuji; Richard N Winn; Thomas Walle
Journal:  Chem Biol Interact       Date:  2006-09-26       Impact factor: 5.192

5.  Structural identification of mouse urinary metabolites of pterostilbene using liquid chromatography/tandem mass spectrometry.

Authors:  Xi Shao; Xiaoxin Chen; Vladimir Badmaev; Chi-Tang Ho; Shengmin Sang
Journal:  Rapid Commun Mass Spectrom       Date:  2010-06-30       Impact factor: 2.419

Review 6.  Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress.

Authors:  J D Hayes; L I McLellan
Journal:  Free Radic Res       Date:  1999-10

7.  Synthesis of cyclic beta-amino acid esters from methionine, allylglycine, and serine.

Authors:  James Gardiner; Kelly H Anderson; Alison Downard; Andrew D Abell
Journal:  J Org Chem       Date:  2004-05-14       Impact factor: 4.354

Review 8.  Molecular basis for chemoprevention by sulforaphane: a comprehensive review.

Authors:  N Juge; R F Mithen; M Traka
Journal:  Cell Mol Life Sci       Date:  2007-05       Impact factor: 9.261

9.  Anti-emetic principles of Magnolia obovata bark and Zingiber officinale rhizome.

Authors:  T Kawai; K Kinoshita; K Koyama; K Takahashi
Journal:  Planta Med       Date:  1994-02       Impact factor: 3.352

10.  Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells.

Authors:  Jennifer Rhode; Sarah Fogoros; Suzanna Zick; Heather Wahl; Kent A Griffith; Jennifer Huang; J Rebecca Liu
Journal:  BMC Complement Altern Med       Date:  2007-12-20       Impact factor: 3.659

View more
  19 in total

1.  Microbiota facilitates the formation of the aminated metabolite of green tea polyphenol (-)-epigallocatechin-3-gallate which trap deleterious reactive endogenous metabolites.

Authors:  Shuwei Zhang; Yantao Zhao; Christina Ohland; Christian Jobin; Shengmin Sang
Journal:  Free Radic Biol Med       Date:  2018-12-19       Impact factor: 7.376

2.  Identification of phase II metabolites of thiol-conjugated [6]-shogaol in mouse urine using high-performance liquid chromatography tandem mass spectrometry.

Authors:  Huadong Chen; Shengmin Sang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-09-18       Impact factor: 3.205

3.  Metabolism of ginger component [6]-shogaol in liver microsomes from mouse, rat, dog, monkey, and human.

Authors:  Huadong Chen; Dominique Soroka; Yingdong Zhu; Shengmin Sang
Journal:  Mol Nutr Food Res       Date:  2013-01-16       Impact factor: 5.914

4.  Characterization of thiol-conjugated metabolites of ginger components shogaols in mouse and human urine and modulation of the glutathione levels in cancer cells by [6]-shogaol.

Authors:  Huadong Chen; Dominique N Soroka; Yuhui Hu; Xiaoxin Chen; Shengmin Sang
Journal:  Mol Nutr Food Res       Date:  2013-01-16       Impact factor: 5.914

5.  [10]-Gingerdiols as the major metabolites of [10]-gingerol in zebrafish embryos and in humans and their hematopoietic effects in zebrafish embryos.

Authors:  Huadong Chen; Dominique N Soroka; Jamil Haider; Karine F Ferri-Lagneau; TinChung Leung; Shengmin Sang
Journal:  J Agric Food Chem       Date:  2013-05-23       Impact factor: 5.279

6.  Cysteine-conjugated metabolite of ginger component [6]-shogaol serves as a carrier of [6]-shogaol in cancer cells and in mice.

Authors:  Huadong Chen; Dominique N Soroka; Yingdong Zhu; Yuhui Hu; Xiaoxin Chen; Shengmin Sang
Journal:  Chem Res Toxicol       Date:  2013-05-15       Impact factor: 3.739

7.  Induction of lung cancer cell apoptosis through a p53 pathway by [6]-shogaol and its cysteine-conjugated metabolite M2.

Authors:  Renaud F Warin; Huadong Chen; Dominique N Soroka; Yingdong Zhu; Shengmin Sang
Journal:  J Agric Food Chem       Date:  2014-01-30       Impact factor: 5.279

8.  Cysteine-conjugated metabolites of ginger components, shogaols, induce apoptosis through oxidative stress-mediated p53 pathway in human colon cancer cells.

Authors:  Junsheng Fu; Huadong Chen; Dominique N Soroka; Renaud F Warin; Shengmin Sang
Journal:  J Agric Food Chem       Date:  2014-05-12       Impact factor: 5.279

9.  Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis.

Authors:  Chunhua Yang; Mingzhen Zhang; Sudeep Lama; Lixin Wang; Didier Merlin
Journal:  J Control Release       Date:  2020-04-23       Impact factor: 9.776

10.  Metabolites of ginger component [6]-shogaol remain bioactive in cancer cells and have low toxicity in normal cells: chemical synthesis and biological evaluation.

Authors:  Yingdong Zhu; Renaud F Warin; Dominique N Soroka; Huadong Chen; Shengmin Sang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.